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and changes in respiratory function. It can also increase the risk of
pulmonary complications and impair functional ability, whichmay
increase length of hospital stay and the associated costs. For these
reasons, surgical and clinical strategies have been adopted to
reduce the duration of chest drainage. Objectives: To evaluate the
efﬁcacy of the addition of intermittent positive airway pressure
applied by the Muller reanimator via a rubber facial mask versus
conventional physiotherapy on the duration of chest drainage
(primary objective), and its effect on the recovery of respiratory
function, length of hospital stay and incidence of pulmonary
complications (secondary objectives). Design: Randomised, con-
trolled trial. Participants and setting: Inpatients with pleural
effusion, aged over 18 years, who have had chest drainage in situ
for < 24 hours will be recruited from two university hospitals.
Patients will be excluded if they have any contraindication for the
use of non-invasive positive airway pressure. Intervention and
control groups: After initial assessments of lung function,
156 patients will be randomised into a positive airway pressure
group (positive airway pressure at 15 cmH2O plus conventional
chest physiotherapy), a conventional chest physiotherapy group
(conventional chest physiotherapy plus non-therapeutic positive
airway pressure at 4 cmH2O) or a control group (non-therapeutic
positive airway pressure at 4 cmH2O). All groups will receive
treatment three times per day for 7 consecutive days. Measure-
ments: A blinded assessor will conduct all assessments. Peripheral
oxygenation and chest drainage output will be measured over
7 consecutive days. Lung function will be re-assessed on Day 4 and
Day 8. The criteria for removal of the chest drain will be a
transudate output  200 ml over 24 hours and full lung expansionhttp://dx.doi.org/10.1016/j.jphys.2014.11.016
1836-9553/ 2014 Australian Physiotherapy Association. Published by Elsevier B.V. Alonchest radiography, as assessedbyablindedphysician.Durationof
chest drainage, length of hospital stay, and any pulmonary
complications diagnosed during hospitalisation will be recorded.
Analysis: Intention to treat using: survival analysis for duration of
chest drainage, and length of hospital stay; analysis of variance for
chest-tube output, lung function and peripheral oxygen saturation;
and chi-square tests for comparing the incidence of pulmonary
complications between groups. Discussion: Conventional chest
physiotherapy and intermittent positive airway pressure breathing
are widely indicated for people with pleural effusion and chest
drains; however, no studies have evaluated the real beneﬁt of this
type of treatment. Our hypothesis is that optimised lung expansion
achieved through the application of intermittent positive airway
pressure will accelerate the reabsorption of pleural effusion,
decrease the duration of chest drainage and respiratory system
impairment, reduce the length of hospital stay, and reduce the
incidence of pulmonary complications.
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